Related Experiment Video
Updated: Sep 26, 2025

The Tail Suspension Test
Published on: January 28, 2012
Insights into Chronic Lithium Toxicity - A Case Report
Giphy Susan Varghese1, Karthikkeyan Rajachandran2, Indhupriyadharshini Murugesan3
1Clinical Pharmacist, Medical Intensive Care Unit, PSG Super Speciality Hospital, Coimbatore, India.
Background:
Bipolar disorder is a chronic psychological disorder, and lithium remains the mainstay of therapy. Lithium toxicity can be acute or chronic and the effects may be disabling or life-threatening. The presence of risk factors can increase the chances of lithium toxicity in a patient on long-term lithium therapy. We hereby report a case of chronic lithium toxicity in a patient with a known case of bipolar disorder.
Case Presentation:
A 44-year-old female patient with a known case of bipolar disorder presented with altered sensorium, seizures, and renal insufficiency. On admission, the patient was severely dehydrated and the serum lithium level was 3.43 mEq/L. Hemodialysis was performed and she improved gradually.
Conclusion:
Lithium has constantly proven to be beneficial in lowering suicide rates in bipolar disorder patients over the years since its approval. However, its use is limited due to the risk of toxicity. The chances of developing toxicity are higher in patients on long-term lithium therapy. Patients with high risk factors for toxicity should be monitored frequently as the effects of lithium toxicity can be fatal.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Chronic Kidney Disease II: Clinical Manifestations

